← All Beta Bionics, INC filings

Beta Bionics, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
BBNX
Beta Bionics, INC
10-K: Beta Bionics Reports Strong iLet Growth, Navigates Regulatory Challenges
Beta Bionics, a medical device company, reported significant revenue growth and increased iLet adoption in its 2025 annual filing, despite ongoing operating losses and regulatory scrutiny.
NASDAQ
BBNX
Beta Bionics, INC
10-K/A: Beta Bionics Corrects Certification Errors in Amended 10-K Filing
Beta Bionics files an amendment to its 2024 annual report to correct administrative errors in executive certifications, with no changes to other financial disclosures.
NASDAQ
BBNX
Beta Bionics, INC
10-K: Beta Bionics Reports Strong Revenue Growth in 2024, Driven by iLet Bionic Pancreas Adoption
Beta Bionics' 10-K filing reveals a significant increase in revenue and installed base for its iLet Bionic Pancreas in 2024, alongside ongoing research and development efforts.